Literature DB >> 24521822

Gaucher disease: plasmalogen levels in relation to primary lipid abnormalities and oxidative stress.

Marina Moraitou1, Evangelia Dimitriou1, Nick Dekker2, Ioannis Monopolis1, Johannes Aerts2, Helen Michelakakis3.   

Abstract

Plasmalogens represent a unique class of phospholipids. Reduced red blood cell plasmalogen levels in Gaucher disease patients were reported, correlating to total disease burden. The relation between plasmalogen abnormalities in Gaucher disease patients and primary glycosphingolipid abnormalities, malonyldialdehyde levels, an indicator of lipid peroxidation, and the total antioxidant status was further investigated. Significant reduction of C16:0 and C18:0 plasmalogens in red blood cells of Gaucher disease patients was confirmed. In parallel, a significant increase in the glucosylceramide/ceramide ratio in red blood cell membranes, as well as an average 200-fold increase in plasma glucosylsphingosine levels was observed. Red blood cell malonyldialdehyde levels were significantly increased in patients, whereas their total antioxidant status was significantly reduced. A negative correlation between plasmalogen species and glucosylceramide, ceramide, glucosylceramide/ceramide ratio, glucosylsphingosine and malonyldialdehyde, significant for the C16:0 species and all the above parameters with the exception of malonyldialdehyde levels, was found along with a positive non-significant correlation with the total antioxidant status. Our results indicate that increased lipid peroxidation and reduced total antioxidant status exist in Gaucher disease patients. They demonstrate a clear link between plasmalogen levels and the primary glycolipid abnormalities characterizing the disorder and an association with the increased oxidative stress observed in Gaucher disease patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ceramide; Gaucher disease; Glucosylceramide; Glucosylsphingosine; Oxidative stress; Plasmalogens

Mesh:

Substances:

Year:  2014        PMID: 24521822     DOI: 10.1016/j.bcmd.2014.01.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  6 in total

Review 1.  Peroxisomes in brain development and function.

Authors:  Johannes Berger; Fabian Dorninger; Sonja Forss-Petter; Markus Kunze
Journal:  Biochim Biophys Acta       Date:  2015-12-11

Review 2.  Ferroptosis and Its Modulation by Autophagy in Light of the Pathogenesis of Lysosomal Storage Diseases.

Authors:  Karolina Pierzynowska; Estera Rintz; Lidia Gaffke; Grzegorz Węgrzyn
Journal:  Cells       Date:  2021-02-10       Impact factor: 6.600

3.  Oxidative stress parameters of Gaucher disease type I patients.

Authors:  Alexandre Silva Mello; Cristina da Silva Garcia; Fernanda de Souza Machado; Niara da Silva Medeiros; Mariane Farias Wohlenberg; Jéssica Pereira Marinho; Caroline Dani; Cláudia Funchal; Janice Carneiro Coelho
Journal:  Mol Genet Metab Rep       Date:  2015-05-22

4.  Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.

Authors:  Wedad Fallatah; Tara Smith; Wei Cui; Dushmanthi Jayasinghe; Erminia Di Pietro; Shawn A Ritchie; Nancy Braverman
Journal:  Dis Model Mech       Date:  2020-01-24       Impact factor: 5.758

5.  Effects of sphingolipids overload on red blood cell properties in Gaucher disease.

Authors:  Lucie Dupuis; Caroline Chipeaux; Emmanuelle Bourdelier; Suella Martino; Nelly Reihani; Nadia Belmatoug; Thierry Billette de Villemeur; Bénédicte Hivert; Fathi Moussa; Caroline Le Van Kim; Marine de Person; Mélanie Franco
Journal:  J Cell Mol Med       Date:  2020-08-07       Impact factor: 5.310

6.  Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.

Authors:  Shoshana Revel-Vilk; Maria Fuller; Ari Zimran
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.